| Periódico |
Artigo |
 |
Volume 3 – Número 2 – ASCO Annual Meeting Proceedings – Post-Meeting Edition (Volume 29 • Número 18 – Suppl • Junho 2011) PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC) – Paz-Ares, L.G. et al. |
 |
Volume 3 – Número 1 – Journal of Clinical Oncology (Volume 28 • Número 6 • Fevereiro 2010) Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial – Sternberg CN et al. |
 |
Volume 2 – Número 4 – New England Journal of Medicine (Volume 355 • Número 24 • Dezembro 2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer – Sandler, A. et al. |
 |
Volume 2 – Número 3 - The Lancet (Volume 374 • Número 9699 • Outubro 2009) Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study – Ciuleanu, T. et al. |
|
Volume 2 – Número 2 – Journal of Clinical Oncology (Volume 28 • Número 12 • Abril 2010) Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignan Glioma: RESCUE Study – Perry, R. et al. |
|
Volume 2 – Número 1 – New England Journal of Medicine (Volume 359 • Número 11 • Setembro 2008) Platinun-Based Chemotherapy Plus Cetuximab in Head and Neck Cancer – Vermorken, J.B. et al. |
|
Volume 1 – Número 4 - The Lancet (Volume 370 • Número 9605 • Dezembro 2007) Bevacizumab Plus Interferon Alfa-2a for Treatment of Metastatic Cell Carcinoma: a Randomised, Double-Blind Phase III Trial – Escudier, B. et al. |
|
Volume 1 – Número 3 - Journal of Clinical Oncology ( Volume 27 • Número 28 • Outubro 2009) Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma - Friedman, H.S. et al |
|
Volume 1 – Número 2 – Journal of Clinical Oncology ( Volume 27 • Número 30 • Outubro 2009) Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer – Gray, R. et al. |
|
Volume 1 – Número 1 – Journal of Clinical Oncology ( Volume 26 • Número 21 • Julho 2008) Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer – Scagliotti, V. et. al. |
